Các con đường tín hiệu tế bào trong bệnh leukodystrophy tự chủ trội (ADLD): vai trò hấp dẫn của tế bào hình sao

Padiath QS, Saigoh K, Schiffmann R et al (2006) Lamin B1 duplications cause autosomal dominant leukodystrophy. Nat Genet 38:1114–1123. https://doi.org/10.1038/ng1872 Nahhas N, Sabet Rasekh P, Vanderver A, Padiath Q (1993) Autosomal dominant leukodystrophy with autonomic disease. University of Washington, Seattle Zanigni S, Terlizzi R, Tonon C et al (2015) Brain magnetic resonance metabolic and microstructural changes in adult-onset autosomal dominant leukodystrophy. Brain Res Bull 117:24–31. https://doi.org/10.1016/j.brainresbull.2015.07.002 Köhler W, Curiel J, Vanderver A (2018) Adulthood leukodystrophies. Nat Rev Neurol 14:94–105 Zhang Y, Li J, Bai R et al (2019) LMNB1-related adult-onset autosomal dominant leukodystrophy presenting as movement disorder: a case report and review of the literature. Front Neurosci 13:1030. https://doi.org/10.3389/fnins.2019.01030 Dai Y, Ma Y, Li S et al (2017) An LMNB1 duplication caused adult-onset autosomal dominant leukodystrophy in Chinese family: clinical manifestations, neuroradiology and genetic diagnosis. Front Mol Neurosci. https://doi.org/10.3389/fnmol.2017.00215 Sandoval-Rodríguez V, Cansino-Torres MA, Sáenz-Farret M et al (2017) Autosomal dominant leukodystrophy presenting as Alzheimer’s-type dementia. Mult Scler Relat Disord 17:230–233. https://doi.org/10.1016/j.msard.2017.08.014 Brussino A, Vaula G, Cagnoli C et al (2010) A family with autosomal dominant leukodystrophy linked to 5q23.2-q23.3 without lamin B1 mutations. Eur J Neurol 17:541–549. https://doi.org/10.1111/j.1468-1331.2009.02844.x Giorgio E, Robyr D, Spielmann M et al (2015) A large genomic deletion leads to enhancer adoption by the lamin B1 gene: a second path to autosomal dominant adult-onset demyelinating leukodystrophy (ADLD). Hum Mol Genet 24:3143–3154. https://doi.org/10.1093/hmg/ddv065 Nmezi B, Giorgio E, Raininko R et al (2019) Genomic deletions upstream of lamin B1 lead to atypical autosomal dominant leukodystrophy. Neurol Genet 5:e305. https://doi.org/10.1212/NXG.0000000000000305 Padiath QS, Fu Y-H (2010) Autosomal dominant leukodystrophy caused by lamin B1 duplications a clinical and molecular case study of altered nuclear function and disease. Methods Cell Biol 98:337–357. https://doi.org/10.1016/S0091-679X(10)98014-X Finnsson J, Sundblom J, Dahl N et al (2015) LMNB1-related autosomal-dominant leukodystrophy: clinical and radiological course. Ann Neurol 78:412–425. https://doi.org/10.1002/ana.24452 Padiath QS (2019) Autosomal dominant leukodystrophy: a disease of the nuclear lamina. Front cell Dev Biol 7:41. https://doi.org/10.3389/fcell.2019.00041 Terlizzi R, Calandra-Buonaura G, Zanigni S et al (2016) A longitudinal study of a family with adult-onset autosomal dominant leukodystrophy: Clinical, autonomic and neuropsychological findings. Auton Neurosci 195:20–26. https://doi.org/10.1016/j.autneu.2016.02.005 Guaraldi P, Donadio V, Capellari S et al (2011) Isolated noradrenergic failure in adult-onset autosomal dominant leukodystrophy. Auton Neurosci Basic Clin 159:123–126. https://doi.org/10.1016/j.autneu.2010.07.011 Eldridge R, Anayiotos CP, Schlesinger S et al (1984) Hereditary adult-onset leukodystrophy simulating chronic progressive multiple sclerosis. N Engl J Med 311:948–953. https://doi.org/10.1056/NEJM198410113111504 Schwankhaus JD, Patronas N, Dorwart R et al (1988) Computed tomography and magnetic resonance imaging in adult-onset leukodystrophy. Arch Neurol 45:1004–1008. https://doi.org/10.1001/archneur.1988.00520330094015 Coffeen CM, McKenna CE, Koeppen AH et al (2000) Genetic localization of an autosomal dominant leukodystrophy mimicking chronic progressive multiple sclerosis to chromosome 5q31. Hum Mol Genet 9:787–793 Melberg A, Hallberg L, Kalimo H, Raininko R (2006) MR characteristics and neuropathology in adult-onset autosomal dominant leukodystrophy with autonomic symptoms. AJNR Am J Neuroradiol 27:904–911 Alturkustani M, Sharma M, Hammond R, Ang LC (2013) Adult-Onset leukodystrophy: review of 3 clinicopathologic phenotypes and a proposed classification. J Neuropathol Exp Neurol 72:1090–1103. https://doi.org/10.1097/NEN.0000000000000008 Giorgio E, Rolyan H, Kropp L et al (2013) Analysis of LMNB1 duplications in autosomal dominant leukodystrophy provides insights into duplication mechanisms and allele-specific expression. Hum Mutat 34:1160–1171. https://doi.org/10.1002/humu.22348 Duncan ID, Radcliff AB (2016) Inherited and acquired disorders of myelin: The underlying myelin pathology. Exp Neurol 283:452–475 Philips T, Rothstein JD (2017) Oligodendroglia: metabolic supporters of neurons. J Clin Invest 127:3271–3280 Verkhratsky A, Nedergaard M (2018) Physiology of astroglia. Physiol Rev 98:239–389. https://doi.org/10.1152/physrev.00042.2016 Ishibashi T, Dakin KA, Stevens B et al (2006) Astrocytes promote myelination in response to electrical impulses. Neuron 49:823–832. https://doi.org/10.1016/j.neuron.2006.02.006 Yue X, Wu L, Hu W (2015) The regulation of leukemia inhibitory factor. Cancer Cell Microenviron. https://doi.org/10.14800/ccm.877 Figlia G, Gerber D, Suter U (2018) Myelination and mTOR. Glia 66:693–707 Azari MF, Profyris C, Karnezis T et al (2006) Leukemia inhibitory factor arrests oligodendrocyte death and demyelination in spinal cord injury. J Neuropathol Exp Neurol 65:914–929. https://doi.org/10.1097/01.jnen.0000235855.77716.25 Banner LR, Moayeri NN, Patterson PH (1997) Leukemia inhibitory factor is expressed in astrocytes following cortical brain injury. Exp Neurol 147:1–9. https://doi.org/10.1006/exnr.1997.6536 Hendriks JJA, Slaets H, Carmans S et al (2008) Leukemia inhibitory factor modulates production of inflammatory mediators and myelin phagocytosis by macrophages. J Neuroimmunol 204:52–57. https://doi.org/10.1016/j.jneuroim.2008.07.015 Bauer S, Patterson PH (2006) Leukemia inhibitory factor promotes neural stem cell self-renewal in the adult brain. J Neurosci 26:12089–12099. https://doi.org/10.1523/JNEUROSCI.3047-06.2006 Chitnis T, Weiner HL (2017) CNS inflammation and neurodegeneration. In: journal of clinical investigation. Am Soc Clin Invest 3577–3587 Columbaro M, Mattioli E, Maraldi NM et al (2013) Oct-1 recruitment to the nuclear envelope in adult-onset autosomal dominant leukodystrophy. Biochim Biophys Acta 1832:411–420. https://doi.org/10.1016/j.bbadis.2012.12.006 Barascu A, Le Chalony C, Pennarun G et al (2012) Oxidative stress induces an ATM-independent senescence pathway through p38 MAPK-mediated lamin B1 accumulation. EMBO J 31:1080–1094. https://doi.org/10.1038/emboj.2011.492 Dreesen O, Chojnowski A, Ong PF et al (2013) Lamin B1 fluctuations have differential effects on cellular proliferation and senescence. J Cell Biol 200:605–617. https://doi.org/10.1083/jcb.201206121 Dreesen O, Ong PF, Chojnowski A, Colman A (2013) The contrasting roles of lamin B1 in cellular aging and human disease. Nucleus 4:283–290. https://doi.org/10.4161/nucl.25808 Wang AS, Ong PF, Chojnowski A et al (2017) Loss of lamin B1 is a biomarker to quantify cellular senescence in photoaged skin. Sci Rep. https://doi.org/10.1038/s41598-017-15901-9 Chojnowski A, Ong PF, Dreesen O (2015) Nuclear lamina remodelling and its implications for human disease. Cell Tissue Res 360:621–631. https://doi.org/10.1007/s00441-014-2069-4 Camps J, Erdos MR, Ried T (2015) The role of lamin Bl for the maintenance of nuclear structure and function. Nucleus 6:8–14. https://doi.org/10.1080/19491034.2014.1003510 Lin S-T, Heng MY, Ptáček LJ, Fu Y-H (2014) Regulation of Myelination in the Central Nervous System by Nuclear Lamin B1 and Non-coding RNAs. Transl Neurodegener 3:4. https://doi.org/10.1186/2047-9158-3-4 Giacomini C, Mahajani S, Ruffilli R et al (2016) Lamin B1 protein is required for dendrite development in primary mouse cortical neurons. Mol Biol Cell 27:35–47. https://doi.org/10.1091/mbc.E15-05-0307 Fukuda S, Kondo T, Takebayashi H, Taga T (2004) Negative regulatory effect of an oligodendrocytic bHLH factor OLIG2 on the astrocytic differentiation pathway. Cell Death Differ 11:196–202. https://doi.org/10.1038/sj.cdd.4401332 Stephens AD, Banigan EJ, Marko JF (2019) Chromatin’s physical properties shape the nucleus and its functions. Curr Opin Cell Biol 58:76–84. https://doi.org/10.1016/j.ceb.2019.02.006 Padiath QS (2016) Lamin B1 mediated demyelination: Linking Lamins, Lipids and Leukodystrophies. Nucleus 7:547–553. https://doi.org/10.1080/19491034.2016.1260799 Mezaki N, Miura T, Ogaki K et al (2018) Duplication and deletion upstream of LMNB1 in autosomal dominant adult-onset leukodystrophy. Neurol Genet 4:e292. https://doi.org/10.1212/NXG.0000000000000292 Ferrera D, Canale C, Marotta R et al (2014) Lamin B1 overexpression increases nuclear rigidity in autosomal dominant leukodystrophy fibroblasts. FASEB J 28:3906–3918. https://doi.org/10.1096/fj.13-247635 Lo Martire V, Alvente S, Bastianini S et al (2018) Mice overexpressing lamin B1 in oligodendrocytes recapitulate the age-dependent motor signs, but not the early autonomic cardiovascular dysfunction of autosomal-dominant leukodystrophy (ADLD). Exp Neurol 301:1–12. https://doi.org/10.1016/j.expneurol.2017.12.006 Bartoletti-Stella A, Gasparini L, Giacomini C et al (2015) Messenger RNA processing is altered in autosomal dominant leukodystrophy. Hum Mol Genet 24:2746–2756. https://doi.org/10.1093/hmg/ddv034 Tofaris GK, Patterson PH, Jessen KR, Mirsky R (2002) Denervated Schwann cells attract macrophages by secretion of leukemia inhibitory factor (LIF) and monocyte chemoattractant protein-1 in a process regulated by interleukin-6 and LIF. J Neurosci 22:6696–6703. https://doi.org/10.1523/jneurosci.22-15-06696.2002 Rittchen S, Boyd A, Burns A et al (2015) Myelin repair invivo is increased by targeting oligodendrocyte precursor cells with nanoparticles encapsulating leukaemia inhibitory factor (LIF). Biomaterials 56:78–85. https://doi.org/10.1016/j.biomaterials.2015.03.044 Roe C (2017) Unwrapping neurotrophic cytokines and histone modification. Cell Mol Neurobiol. https://doi.org/10.1007/s10571-016-0330-y Aloisi F, Rosa S, Testa U et al (1994) Regulation of leukemia inhibitory factor synthesis in cultured human astrocytes. J Immunol 152:5022–5031 Butzkueven H, Zhang JG, Soilu-Hanninen M et al (2002) LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat Med 8:613–619. https://doi.org/10.1038/nm0602-613 Butzkueven H, Emery B, Cipriani T et al (2006) Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss. Glia 53:696–703. https://doi.org/10.1002/glia.20321 Shimi T, Goldman RD (2014) Nuclear lamins and oxidative stress in cell proliferation and longevity. Adv Exp Med Biol 773:415–430. https://doi.org/10.1007/978-1-4899-8032-8_19 Ratti S, Follo MY, Ramazzotti G et al (2019) Nuclear phospholipase C isoenzyme imbalance leads to pathologies in brain, hematologic, neuromuscular, and fertility disorders. J Lipid Res 60:312–317. https://doi.org/10.1194/jlr.R089763 Fiume R, Ramazzotti G, Teti G et al (2009) Involvement of nuclear PLCbeta1 in lamin B1 phosphorylation and G2/M cell cycle progression. FASEB J 23:957–966. https://doi.org/10.1096/fj.08-121244 Ratti S, Ramazzotti G, Faenza I et al (2018) Nuclear inositide signaling and cell cycle. Adv Biol Regul 67:1–6. https://doi.org/10.1016/j.jbior.2017.10.008 Giorgio E, Lorenzati M, di Val R, Cervo P et al (2019) Allele-specific silencing as treatment for gene duplication disorders: proof-of-principle in autosomal dominant leukodystrophy. Brain. https://doi.org/10.1093/brain/awz139